Back
ALPS REIT Dividend Dogs ETF Vs. Collegium Pharmaceutical Industry Stock Comparison
Sell
31
RDOG
ALPS REIT Dividend Dogs ETF
Last Price:
$36.90
Seasonality Move:
-1.23%
Sell
45
COLL
Collegium Pharmaceutical
Last Price:
$33.33
Seasonality Move:
-1.63%
Sell
31
ALPS REIT Dividend Dogs ETF (RDOG)
is a Sell
Is ALPS REIT Dividend Dogs ETF a Buy, Sell or Hold?
-
The current ALPS REIT Dividend Dogs ETF [RDOG] share price is $37.16. The Score for RDOG is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.
-
RDOG is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
45
Collegium Pharmaceutical (COLL)
is a Sell
Is Collegium Pharmaceutical a Buy, Sell or Hold?
-
The current Collegium Pharmaceutical [COLL] share price is $33.34. The Score for COLL is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
-
COLL is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
RDOG Stock Price Chart
What is ALPS REIT Dividend Dogs ETF's stock price today?
-
The ALPS REIT Dividend Dogs ETF share price today is $37.16Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RDOG is experiencing buying pressure, which is a positive indicator for future bullish movement.
COLL Stock Price Chart
What is Collegium Pharmaceutical's stock price today?
-
The Collegium Pharmaceutical share price today is $33.34Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and COLL is experiencing buying pressure, which is a positive indicator for future bullish movement.
RDOG Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.91 | Sell |
Relative Strength Index (14 RSI): | 30.55 | Sell |
Chaikin Money Flow: | 774 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (37.61 - 40.97) | Sell |
Bollinger Bands (100): | (39.29 - 41.97) | Sell |
COLL Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.27 | Sell |
Relative Strength Index (14 RSI): | 66.05 | Buy |
Chaikin Money Flow: | 1007158 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (28.9 - 30.94) | Buy |
Bollinger Bands (100): | (30.52 - 37.92) | Sell |
RDOG Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 37.58 | Sell |
20-day SMA: | 38.77 | Sell |
50-day SMA: | 40 | Sell |
200-day SMA: | 38.81 | Sell |
8-day EMA: | 37.64 | Sell |
20-day EMA: | 38.53 | Sell |
50-day EMA: | 39.6 | Sell |
200-day EMA: | 39.15 | Sell |
COLL Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 29.45 | Buy |
20-day SMA: | 29.79 | Buy |
50-day SMA: | 30.91 | Buy |
200-day SMA: | 34.47 | Sell |
8-day EMA: | 30.02 | Buy |
20-day EMA: | 29.94 | Buy |
50-day EMA: | 31.21 | Buy |
200-day EMA: | 32.94 | Buy |
ALPS REIT Dividend Dogs ETF Earnings Growth & RDOG Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Collegium Pharmaceutical Earnings Growth & COLL Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.11 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.42 per share, and an increase next year of $0.51 per share.
ALPS REIT Dividend Dogs ETF Technical Analysis
Dec 24 | Dec 26 | Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | Jan 6 | Jan 7 | Jan 8 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | Jan | |||||||||
24 | 26 | 27 | 30 | 31 | 02 | 03 | 06 | 07 | 08 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Collegium Pharmaceutical Technical Analysis
Dec 24 | Dec 26 | Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | Jan 6 | Jan 7 | Jan 8 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | Jan | |||||||||
24 | 26 | 27 | 30 | 31 | 02 | 03 | 06 | 07 | 08 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |